Jobs / United States / Glaxosmithkline LLC
Medical Director, Multiple Myeloma
Glaxosmithkline LLC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Sr Manager - Oncology Commercial Analytics, Multiple Myeloma” (Data Scientists) in PA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Position Summary A Medical Affairs Medical Director has strong clinical and scientific training and can take on many aspects of medical affairs work (insight generation, scientific communications, external scientific engagement, provision of medical advice to internal stakeholders). The focus of the Medical Director is to provide input and expertise into the medicine strategy, develop and execute the related tactical plans, support external scientific engagement, and provide insight and deeper understanding of the data generated including recommending medical statements. Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Supports the US Medical Affairs Lead with development and execution of US medical affairs plans, and as needed. • Leads planning and execution of medical tactics; contributes to medical material development, communication plans, application of external stakeholder insights. • Partners with Medical Communications & Scientific Training and Medical Information to ensure medical materials created align with US medical strategy and business needs. • Understands, interprets, and applies the external environment and competitive knowledge to all medical activities and can define the patient journey. • Provides input into the selection of US investigator sponsored studies in alignment with the global franchise. • Understands and communicates clinical and market access data requirements for the US market; in partnership with the US Medical Affairs Lead, provides input to shape clinical and health outcomes evidence plans to support anticipated US Market needs. • In partnership with the US Medical Affairs Lead, provides input into the design of clinical trials, development plans, and integrated evidence planning; coordinates with relevant Global Medical colleagues and R&D (Research & Development) technical experts, e.g., Global Value Evidence and Outcomes and Epidemiology, as required. • In collaboration with field medical, leads/contributes to appropriate US scientific engagement between GSK and external stakeholders/accounts to advance scientific and medical understanding including the appropriate development and use of our medicines, management of the disease, and patient care. • Partners with all relevant internal stakeholders to ensure successful execution of all medical activities to support life cycle management, ensuring integrity of scientific content. • Applies sound medical governance for all activities. Work arrangement: This role is hybrid. You will work from home and on-site as needed for team collaboration, stakeholder meetings, and key events. Some travel will be required for meetings and conferences. Basic Qualifications: We are seeking professionals with the following required skills and qualifications to help us achieve our goals: • PharmD, PhD, MD or advanced degree. • 4+ years industry and/or clinical experience in the oncology therapeutic area. • Demonstrated success leading and managing cross-functional work. • Disease and therapeutic area knowledge. • Robust experience networking, communication, and influencing to work effectively in a complex matrix environment. • Demonstrated ability to build strong internal and external networks. Preferred Qualifications: If you have the following characteristics, it would be a plus: Education and credentials • Advanced clinical or scientific doctorate (MD, PharmD, PhD) with hematology/oncology specialization. • Board certification or residency/fellowship training in hematology, oncology, or oncology pharmacy (BCOP). • Formal training in clinical research, epidemiology, or implementation science. Therapeutic area depth • Direct e